Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections

S

SpeeDx

Status

Not yet enrolling

Conditions

Gonorrhea
Diagnosis
Resistance Bacterial

Study type

Observational

Funder types

Other
Industry
Other U.S. Federal agency

Identifiers

NCT06352554
75A50122C00028 (Other Grant/Funding Number)
2023/ETH02474:STING
224842/Z/21/Z (Other Grant/Funding Number)

Details and patient eligibility

About

This study aims to validate a novel antibiotic susceptibility test (InSignia) for gonorrhoea in patient clinical samples. The hypothesis is that the InSignia test will be able to detect transcriptional responses after incubation in antibiotic for susceptible strains and not resistant strains. Furthermore, this study will also add to our understanding on the performance of this test in various clinical specimens.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Confirmed/suspected NG infection
  • Willingness to give written informed consent as well as to participate in and comply with the study.

Exclusion criteria

  • Currently taking or having taken any antibiotics in the preceding 14 days
  • English fluency below level required to understand study procedures
  • Unwilling or unable to comply with study procedures

Trial contacts and locations

0

Loading...

Central trial contact

Nicole Lima

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems